Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Mycobacterium research and diagnosis

Mycobacterium research and diagnosis is a research topic within Epidemiology. Science Explorer counts 50k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, treatment, and epidemiology of nontuberculous mycobacterial diseases, with a particular emphasis on Mycobacterium avium and Mycobacterium abscessus. It covers topics such as the impact of genotypic studies, antibiotic resistance, prevalence in specific patient populations (e.g., Crohn's disease, cystic fibrosis), and environmental sources. The cluster also delves into genomic and comparative genomic studies supporting the division of the genus Mycobacterium.

  • Nontuberculous Mycobacteria
  • Mycobacterium avium
  • Mycobacterium abscessus
  • Epidemiology
  • Diagnosis
  • Treatment
  • Genomic Studies
  • Crohn's Disease
  • Cystic Fibrosis
  • Antibiotic Resistance
Research works
50k
fractional, since 1950
In the world top 10%
5.1k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-4%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Mycobacterium research and diagnosis

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Mycobacterium research and diagnosis research?

By volume, the United States and China publish the most (1.5k and 1.2k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.5k works
  2. 2 China 1.2k works
  3. 3 India 696 works
  4. 4 Japan 391 works
  5. 5 United Kingdom 285 works
  6. 6 Brazil 279 works
  7. 7 South Korea 217 works
  8. 8 France 213 works
  9. 9 Spain 185 works
  10. 10 Germany 182 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 29.8%China: 22.9%India: 13.5%Japan: 7.6%6 others listed: 26.3%30%largest
United States1,543 · 29.8%China1,186 · 22.9%India696 · 13.5%Japan391 · 7.6%6 others listed1,361 · 26.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Mycobacterium research and diagnosis research?

By volume in 2022-now, Capital Medical University publishes the most Mycobacterium research and diagnosis research, followed by Harvard University and All India Institute of Medical Sciences.

Who are the leading researchers in Mycobacterium research and diagnosis?

The most-cited researchers publishing on Mycobacterium research and diagnosis include Eric S. Lander, Rob Knight and Mark J. Daly.

  1. 1 Eric S. Lander United States 524k citations
  2. 2 Rob Knight United States 468k citations
  3. 3 Mark J. Daly United States 403k citations
  4. 4 Peer Bork Germany 396k citations
  5. 5 Guido Kroemer France 386k citations
  6. 6 Steven L. Salzberg United States 372k citations
  7. 7 Hermann Brenner Germany 343k citations
  8. 8 Shizuo Akira Japan 342k citations
  9. 9 Jun Wang China 340k citations
  10. 10 Matthias Egger Switzerland 326k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Mycobacterium research and diagnosis?

The most cited paper in Mycobacterium research and diagnosis is "A new mathematical model for relative quantification in real-time RT-PCR" (Michael Walter Pfaffl, 2001), with 35,329 citations. Next come "Antibiotic Susceptibility Testing by a Standardized Single Disk Method" (18,626) and "Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence" (7,928).

Most cited papers
#PaperReleasedCitations
1 A new mathematical model for relative quantification in real-time RT-PCR Michael Walter Pfaffl · Nucleic Acids Research Open access May 2001 35,329
2 Antibiotic Susceptibility Testing by a Standardized Single Disk Method Alfred W. Bauer, William M. M. Kirby, J. C. Sherris et al. · American Journal of Clinical Pathology Apr 1966 18,626
3 Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Stewart Thomas Cole et al. · Nature Open access Jun 1998 7,928
4 An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases David E. Griffith, Timothy R. Aksamit, Barbara A. Brown‐Elliott et al. · American Journal of Respiratory and Critical Care Medicine Feb 2007 6,190
5 Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy Ayelet Sivan, Leticia Corrales, Nathaniel J. Hubert et al. · Science Open access 5 Nov 2015 3,900
All 100 most cited papers, with filters and sorting

Where is Mycobacterium research and diagnosis research done?

The largest centres of Mycobacterium research and diagnosis research in 2022-now are Beijing (China), Tokyo (Japan), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Denver and Cape Town.

Largest cities, 2022-now

  1. 1 BeijingChina 194 works
  2. 2 TokyoJapan 128 works
  3. 3 ShanghaiChina 104 works
  4. 4 SeoulSouth Korea 103 works
  5. 5 LondonUnited Kingdom 101 works
  6. 6 New DelhiIndia 85 works
  7. 7 ParisFrance 84 works
  8. 8 GuangzhouChina 78 works
  9. 9 HangzhouChina 69 works
  10. 10 New YorkUnited States 69 works

Where it is the local speciality

  1. DenverUS · 38.5 works8.0×
  2. Cape TownZA · 22.9 works7.5×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Mycobacterium research and diagnosis than the world average.

See Mycobacterium research and diagnosis on the map

Where is the best place to study Mycobacterium research and diagnosis?

Among universities, judged by research, Harvard University, University of Pittsburgh and Capital Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 18.07%fractional works in this field (log) →share of work in the world top 10% →University of Pittsb…Radboud University N…Harvard UniversityCapital Medical Univ…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 64.917.3%2.0×42 -0.2%
2University of PittsburghUnited States 62.126.3%3.0×16 -3.0%
3Capital Medical UniversityChina 59.111.2%7.7×54 +17.9%
4Radboud University NijmegenNetherlands 59.120.8%4.5×18 -4.9%
5Zhejiang UniversityChina 58.519.4%2.1×37 +96.6%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 54.615.1%4.5×31 +36.3%
7Sichuan UniversityChina 54.317.6%2.2×33 +27.2%
8London School of Hygiene & Tropical MedicineUnited Kingdom 53.424.5%9.5×10 -34.6%
9University of Colorado DenverUnited States 52.013.0%9.3×20 -0.8%
10Fudan UniversityChina 51.015.5%3.0×31 +6.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Mycobacterium research and diagnosis, country by country

Is Mycobacterium research and diagnosis research growing?

Output in 2022-2025 was 4% lower than in 2018-2021, peaking in 2019.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Mycobacterium research and diagnosis as a percentage of every work published that year, 0.033% in 2024.

still counting0.025%0.050%0.075%Mycobacterium research and diagnosis0.029% in 202519801990200020102020

Fractional works of Mycobacterium research and diagnosis over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Mycobacterium research and diagnosis10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Mycobacterium research and diagnosis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.